Article tools
Author information
Published in Volume 78, Issue 4 (October,1986)
J. Clin. Invest. 78(4): 1120-1124 (1986). doi:10.1172/JCI112669.
Copyright © 1986, The American Society for Clinical Investigation.

Research Article

Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).

J F Balavoine, B de Rochemonteix, K Williamson, P Seckinger, A Cruchaud and J M Dayer

Published October, 1986

Interleukin 1 (IL-1) possesses multiple biological activities that may be blocked selectively by different inhibitors. Some known inhibitors block the lymphocyte activating factor (LAF/IL-1) but not the mononuclear cell factor (MCF/IL-1) measured by its capacity to stimulate prostaglandin E2 (PGE2) and collagenase production. The presence of IL-1 in vivo may be difficult to detect due to the presence of inhibitor(s) and the level of the inhibitor(s) may vary depending upon pathological conditions. We have found that urine from three patients with monocytic leukemia (M5) contained high levels of inhibitor(s) of MCF/IL-1, whereas urine of normal subjects did not contain significant amounts. Urine from two patients with other blood neoplasic diseases also contained little inhibitory activity. The MCF/IL-1 inhibitor(s), which also acts on human recombinant IL-1 beta, is approximately 25-35 kD, is not retained on concanavalin A-Sepharose column and can be partially destroyed with urea and boiling. At this stage of the purification the fraction containing the MCF/IL-1 inhibitor(s) also inhibits the LAF/IL-1 assay. However, this inhibitor(s) is probably distinct from other inhibitors already described.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1120
icon of scanned page 1121
icon of scanned page 1122
icon of scanned page 1123
icon of scanned page 1124
This article Copyright © 1986, The American Society for Clinical Investigation.

Articles that cite
this article:

The development of anticytokine therapeutics for rheumatic diseases
William P. Arend, Mary B. Goldring
Arthritis Rheum 58(s2):S102. [CrossRef]

The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis
George D Kalliolias, Stamatis-Nick C liossis
Expert Opin Invest Drugs 17(3):349. [CrossRef]

Purification and characterization of a 26-kDa competitive inhibitor of interleukin 1
Gonzalo J. Mazzei, Philippe L. Seckinger, Jean-Michel Dayer, Alan R. Shaw
Eur J Immunol 20(3):683. [CrossRef]

Interleukin-1
CHARLES A. Dinarello
Ann N Y Acad Sci 546(1 molecular bas):122. [CrossRef]

Micellar electrokinetic chromatographic and capillary zone electrophoretic methods for screening urinary biomarkers of human disorders: A critical review of the state-of-the-art
Paolo Iadarola, Giuseppe Cetta, Maurizio Luisetti, Laura Annovazzi, Begona Casado, James Baraniuk, Chiara Zanone, Simona Viglio
Eletrophoresis 26(4-5):752. [CrossRef]

Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate
Pio Conti, Marcella Reale, Maria Rosaria Panara, Stavros Fridas, Fernanda C. Placido, Renato C. Barbacane
Calcif Tissue Int 52(4):300. [CrossRef]

Cytokines and proteoglycans
J. J. Nietfeld
CMLS Cell Mol Life Sci 49(5):456. [CrossRef]

Interleukin-1 and the response to injury
Elliot Kaplan, Charles A. Dinarello, Jeffrey A. Gelfand
IR 8(2):118. [CrossRef]

Role of Interleukin-l in Infectious Diseases
Charles A. Dinarello
Immunol Rev 127(1):119. [CrossRef]

Psoriatic skin reveals the in vivo presence of an epidermal IL-1 inhibitor
N.-I. Kim, K. D. Cooper, G. J. Fisher, O. Baadsgaard, J. J. Voorhees, C. Hammerberg
Arch Dermatol Res 284(2):71. [CrossRef]

IgG Induction of IL-1 Receptor Antagonist Production by Human Monocytes
William P. Arend, Donald Y. M. Leung
Immunol Rev 139(1):71. [CrossRef]

Activation of the peroxisome proliferator–activated receptor α pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes
Mathias François, Pascal Richette, Lydia Tsagris, Catherine Fitting, Cedric Lemay, Mourad Benallaoua, Khadija Tahiri, Marie-Therese Corvol
Arthritis Rheum 54(4):1233. [CrossRef]

Inhibition of Interleukin-1 (Alpha and Beta), Interleukin-2 Secretion and Surface Expression of Interleukin-2 Receptor (IL-2R) by a Novel Cytokine Interleukin-1 Receptor Antagonist (IL-lra)
P. Conti, M. R. Panara, A. M. Porrini, D. Gambi, R. C. Barbacane, M. Reale, M. Bongrazio, R. A. Dempsey
Scand J Immunol 36(1):27. [CrossRef]

Role for interleukin-1 in the pathogenesis of hypersensitivity diseases
Charles A. Dinarello, Stefan Endres
J Cell Biochem 39(3):229. [CrossRef]

Dual biological functions of an interleukin-1 receptor antagonist-interleukin-10 fusion protein and its suppressive effects on joint inflammation
Deh-Ming Chang, Song-Kun Shyue, Shao-Hsiang Liu, Yen-Teen Chen, Chiou-Yueh Yeh, Jenn-Huang Lai, Herng-Sheng Lee, Ann Chen
IMMUNOL 112(4):643. [CrossRef]

Interleukin-1 Receptor Antagonist Suppresses Contact Hypersensitivity.
Seiji Kondo, Saveria Pastore, Hiroshi Fujisawa, Gulnar M. Shivji, Roderick C. Mckenzie, Charles A. Dinarello, Daniel N. Sauder
J Invest Dermatol 105(3):334. [CrossRef]

Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes
Pio Conti, Maria R. Panara, Renato C. Barbacane, Marcella Reale, Mauro Bongrazio, Roy A. Dempsey
Agents Actions 36(s1):C93. [CrossRef]

Inhibition of leukotriene B4(LTB4) by recombinant interleukin-1 receptor antagonist (IL-1RA) on human monocytes
Pio Conti, Maria R. Panara, Renato C. Barbacane, Marcella Reale, Mauro Bongrazio, Roy A. Dempsey
Agents Actions 36(3-4):C93. [CrossRef]

The pathophysiology of the pro-inflammatory cytokines
Charles A. Dinarello
2(3):189. [CrossRef]

Interleukin-1–inhibitory IgG in sera from some patients with rheumatoid arthritis
Hiroshi Suzuki, Takao Akama, Masato Okane, Ichiro Kono, Yoshiki Matsui, Kazuhide Yamane, Heihachiro Kashiwagi
Arthritis Rheum 32(12):1528. [CrossRef]

IL-1 and IL-6 release by tumor-associated macrophages from human ovarian carcinoma
Annalaura Erroi, Marina Sironi, Francesca Chiaffarino, Chen Zhen-guo, Manuela Mengozzi, Alberto Mantovani
Int J Cancer 44(5):795. [CrossRef]

Interleukin-1α gene expression and localization of interleukin-1α protein during tumor promotion
Tatiana M. Oberyszyn, Carol L. K. Sabourin, Gautam N. Bijur, Andrew S. Oberyszyn, Laszlo G. Boros, Fredika M. Robertson
Mol Carcinog 7(4):238. [CrossRef]

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
William P. Arend, Jean-Michel Dayer
Arthritis Rheum 33(3):305. [CrossRef]

Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus
Dan Aderka, Arjeh Wysenbeek, Hartmut Engelmann, Andrew P. Cope, Fionula Brennan, Yair Molad, Vered Hornik, Yoram Levo, Ravinder N. Maini, Marc Feldmann
Arthritis Rheum 36(8):1111. [CrossRef]

Evidence for Fibroblast Heterogeneity
MARC E. Goldyne
Ann N Y Acad Sci 548(1 endocrine):108. [CrossRef]

Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis
Gary S. Firestein, David L. Boyle, Carolyn Yu, Mary M. Paine, Teri D. Whisenand, Nathan J. Zvaifler, William P. Arend
Arthritis Rheum 37(5):644. [CrossRef]

Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression
John P. Caron, Julio C. Fernandes, Johanne Martel-pelletier, Ginette Tardif, François Mineau, Changshan Geng, Jean-Pierre Pelletier
Arthritis Rheum 39(9):1535. [CrossRef]

Modulation of the effects of interleukin-1 on glycosaminoglycan synthesis by the urine-derived interleukin-1 inhibitor, but not by interleukin-6
Philippe Seckinger, Ilana Yaron, Frank A. Meyer, Michael Yaron, Jean-Michel Dayer
Arthritis Rheum 33(12):1807. [CrossRef]

In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice
Henk M. Van beuningen, Onno J. Arntz, Wim B. Van den berg
Arthritis Rheum 34(5):606. [CrossRef]

Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells
Fabio Re, Manuela Mengozzi, Marta Muzio, Charles A. Dinarello, Alberto Mantovani, Francesco Colotta
Eur J Immunol 23(2):570. [CrossRef]

Blocking interleukin-1 receptors
Charles A. Dinarello
IJ Clinical & Laboratory Research 24(2):61. [CrossRef]

Strategy of Leukocyte Filtration for Immunomodulation: Development of Stainless Steel Leukocyte Filter
Ken Yamaji, Shingo Yamane, Yoshinari Niimi, Akinori Sueoka, Yukihiko Nosé
Therapher Dial 1(1):63. [CrossRef]

Cytokines and preterm labour
Moshe Mazor, José Cohen, Roberto Romero, Fabio Ghezzi, Jorge E Tolosa, Ricardo Gomez
Fet Mat Med Rev 7(4):207. [CrossRef]